Is MNMD or EQR a better dividend investment in 2026?

MNMD currently yields 10.58% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: MNMD offers higher current income.

What is the dividend yield difference between MNMD and EQR?

MNMD has a forward dividend yield of 10.58% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 5.85 percentage points.

Home › Compare › MNMD vs EQR

MNMD vs EQR: Dividend Comparison 2026

MNMD yields 10.58% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EQR wins by $228.00 in total portfolio value· pulled ahead in Year 10

INVESTMENT

TIME HORIZON10 years

MNMD

● Live price

10.58%

Share price

$18.91

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.2K

Annual income

$2,053.05

Full MNMD calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — MNMD vs EQR

📍 EQR pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MNMD	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MNMD + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MNMD pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNMD

Annual income on $10K today (after 15% tax)

$899.00/yr

After 10yr DRIP, annual income (after tax)

$1,745.09/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, EQR beats the other by $1,501.58/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNMD + EQR for your $10,000?

MNMD: 50%EQR: 50%

100% EQR50/50100% MNMD

Portfolio after 10yr

$40.4K

Annual income

$2,936.32/yr

Blended yield

7.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MNMD

Analyst Ratings

Buy

Consensus: Buy

Price Target

$28.00

+48.1% upside vs current

Range: $28.00 — $28.00

Altman Z

5.2

Piotroski

2/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNMD buys

EQR buys

No recent congressional trades found for MNMD or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMNMDEQR

Forward yield	10.58% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$40.2K	$40.5K ✓
Annual income after 10y	$2,053.05	$3,819.61 ✓
Total dividends collected	$15.5K	$16.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold
Analyst price target	$28.00	$70.35 ✓

Year-by-year: MNMD vs EQR ($10,000, DRIP)

Year	MNMD Portfolio	MNMD Income/yr	EQR Portfolio	EQR Income/yr	Gap
1	$11,758	$1,057.64	$11,248	$547.57	+$510.00 → MNMD
2	$13,743	$1,162.18	$12,701	$666.53	+$1.0K → MNMD
3	$15,974	$1,269.54	$14,405	$814.59	+$1.6K → MNMD
4	$18,472	$1,379.15	$16,413	$999.84	+$2.1K → MNMD
5	$21,255	$1,490.43	$18,795	$1,232.92	+$2.5K → MNMD
6	$24,346	$1,602.82	$21,639	$1,527.95	+$2.7K → MNMD
7	$27,766	$1,715.78	$25,057	$1,903.80	+$2.7K → MNMD
8	$31,538	$1,828.79	$29,197	$2,385.87	+$2.3K → MNMD
9	$35,687	$1,941.36	$34,250	$3,008.70	+$1.4K → MNMD
10← crossover	$40,239	$2,053.05	$40,467	$3,819.61	$228.00 → EQR

MNMD vs EQR: Complete Analysis 2026

MNMD — Stock

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Full MNMD Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this MNMD vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNMD vs SCHD MNMD vs JEPI MNMD vs O MNMD vs KO MNMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.